Oragenics Inc.
OGEN | AMEX
$0.52
$0 (+0.02%)
Sep 22, 2026, 3:59 PM ET · Market open
Market Data
Market Cap $2.34M
Enterprise Value $-1.71M
Beta 1.25
Average Volume 40.35K
Shares Outstanding (Diluted) 4.43M
Shares Change YoY 60416.07%
Institutional Ownership 4.43%
Exchange AMEX
ISIN US6840236094
Price Performance
Price Change 1M -12.7%
Price Change 3M -17.0%
Price Change 6M -29.4%
Price Change YTD -42.5%
Price Change 1Y -60.3%
Price Change 3Y -99.5%
Price Change 5Y -100.0%
1M CAGR (ann.) -5.5%
1Y CAGR (ann.) -57.1%
5Y CAGR (ann.) -78.7%
All-Time CAGR -48.7%
Valuation
PE Ratio -0.13
Forward PE N/A
PEG Ratio -0.00
Forward PEG 0.00
PS Ratio N/A
Forward PS N/A
PB Ratio 0.59
P/FCF Ratio -0.21
P/Adj. FCF Ratio -0.21
P/OCF Ratio -0.21
EV/Sales N/A
EV/EBIT 0.17
EV/EBITDA 0.24
EV/FCF 0.17
Earnings Yield -745.8%
FCF Yield -474.6%
Adj. FCF Yield -479.7%
Financial Health
Net Cash $3.86M
Total Debt $0
Cash & Short-Term Investments $3.86M
Total Assets $5.49M
Current Ratio 3.01
Quick Ratio 3.01
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage -561.90
Altman Z-Score -63.57
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -1.1%
Returns
Return on Assets -183.6%
Return on Equity -144.2%
Return on Invested Capital -279.5%
Return on Capital Employed -285.3%
Return on Tangible Assets -183.6%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y 54.5%
EPS CAGR 3Y 28.1%
EPS CAGR 5Y 11.9%
EPS CAGR 10Y 33.4%
FCF CAGR 3Y -18.1%
FCF CAGR 5Y 13.9%
FCF CAGR 10Y 0.1%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y 36.0%
Revenue Growth Next 3Y N/A
Earnings Date Nov 15, 2026
EPS Estimate (next Q) -$90
EPS Growth Est (next Q) 4491.8%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Cash Flow
Operating Cash Flow $-10.21M
Free Cash Flow $-10.21M
Adj. Free Cash Flow $-10.32M
FCF Per Share -$2.30
OCF Per Share -$2.30
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $0
Operating Income $-10.47M
EBITDA $-7.15M
Net Income $-10.08M
EPS (Diluted) -$3.58
Revenue / Employee N/A
Profit / Employee $-3.36M
Employees 3
Add to Watchlist
Select watchlists to add or remove OGEN